Organogenesis Holdings Inc.ORGONASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+48.3%
Year-over-Year Change
Year-over-year SG&A expense growth
5Y CAGR
+48.3%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
7.2x
Strong expansion
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 26.44% |
| Q3 2025 | 7.34% |
| Q2 2025 | 1.79% |
| Q1 2025 | -1.82% |
| Q4 2024 | 2.87% |
| Q3 2024 | -6.20% |
| Q2 2024 | 5.83% |
| Q1 2024 | 17.82% |
| Q4 2023 | -4.42% |
| Q3 2023 | -8.67% |
| Q2 2023 | -4.76% |
| Q1 2023 | 8.11% |
| Q4 2022 | -13.91% |
| Q3 2022 | 9.25% |
| Q2 2022 | 14.20% |
| Q1 2022 | -5.46% |
| Q4 2021 | 7.83% |
| Q3 2021 | 0.03% |
| Q2 2021 | 7.07% |
| Q1 2021 | 9.42% |
| Q4 2020 | 3.69% |
| Q3 2020 | 10.37% |
| Q2 2020 | -11.62% |
| Q1 2020 | 0.47% |
| Q4 2019 | 5.85% |
| Q3 2019 | 1.06% |
| Q2 2019 | 0.13% |
| Q1 2019 | 2.98% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |